NCT07687121

Brief Summary

This two-phase, mixed-methods approach project aims to develop a community-based, participatory, and co-created TB/TB infection (TBI) screening care pathway for African and Hindustan immigrants, who often face socioeconomic vulnerabilities and barriers to healthcare access, including TB/TBI screening. The first phase involves the co-design of a TB/TBI screening care pathway through four thematic workshops using the Double-Diamond theoretical framework. These workshops will engage key stakeholders, including immigrants, community leaders, healthcare professionals, and academics, to identify barriers, define needs, and develop actionable measures to improve TB/TBI screening care. The second phase involves a community-based study to implement the care pathway and estimate the incidence of TB and TBI among 200 immigrants from Angola, Cabo Verde, Guinea-Bissau, Mozambique, India, Bangladesh, and Nepal. Participants will be recruited through Grupcommunity services, and data will be collected on demographic, socioeconomic, health, and migration-related factors. The screening pathway will be implemented and evaluated, with patient-related outcomes measured to assess its effectiveness. The primary outcomes include the development of a culturally sensitive TB/TBI screening care pathway and the estimation of TB and TBI incidence among high-risk immigrant populations. Secondary outcomes include the profiling of immigrant populations, the identification of social vulnerabilities, and the establishment of eligibility criteria for TB/TBI screening in similar populations. We expected to advance knowledge on the specific needs of vulnerable immigrants regarding TB/TBI screening and care and to empower communities, improve access to healthcare, and inform policymakers on tailored prevention and control strategies. The findings will contribute to the global effort to eliminate TB by addressing the unique challenges faced by immigrant populations in low-incidence countries like Portugal.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Dec 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 7, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2026

Expected
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

July 7, 2026

Status Verified

June 1, 2026

Enrollment Period

5 months

First QC Date

June 12, 2026

Last Update Submit

June 29, 2026

Conditions

Keywords

ImmigrantsMigrantsTuberculosisSurveillanceScreeningCare pathway

Outcome Measures

Primary Outcomes (2)

  • Incidence of TB

    Number of TB positive immigrants / Total immigrants screened

    Baseline

  • Incidence of TB infection

    Number of participants positive for TB infection / All participants screened

    Baseline

Secondary Outcomes (1)

  • Immigrant profile

    Baseline

Study Arms (1)

Immigrants

Immigrants in Portugal that have started migration journey less than 5 years before the data collcetion for the study, originated from Angola, Mozambique, Guinea Bissau, Cape Verde, Bangladesh, India or Nepal

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We will use a sequential non-probability sampling method. Eligible participants will be recruited consecutively from community services in Lisbon and associated community networks during the defined data collection period, until the planned sample size is reached or until the end of the recruitment period (6 months after the first workshop). We plan to include approximately 200 participants. This sample size was determined by the operational capacity of the services involved, specifically capacity for community recruitment and participant follow-up, and the capacity of the TB community services for clinical evaluation, diagnosis, treatment decisions, and follow-up when necessary.

You may qualify if:

  • \- adult immigrants, aged 18 years or older, from Angola, Cape Verde, Guinea-Bissau, Mozambique, India, Bangladesh, or Nepal, who began their migration journey less than five years ago, who attend or are identified through community services or associated community networks, and who agree to participate by signing an informed consent form.

You may not qualify if:

  • Participants with a legally appointed representative
  • Participants incapable of understanding essential study information, even with linguistic or cultural mediation support and with any clinical condition that prevents the interview, informed consent, or screening process

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Direção Geral da Saúde. (2023). Guia Cuidados de Saúde em Tuberculose para Populações Vulneráveis . Direção Geral da Saúde. https:// www.dgs.pt/tuberculose/ficheiro-de-registos-folhetos/guia-tb-populacoes-vulneraveis_mar2023-pdf.aspx

    BACKGROUND
  • Direção Geral da Saúde. (2022). Recomendações de rastreio de Tuberculose em cidadãos provenientes de paises de alta incidência de TB . https://www.chporto.pt/images/noticias/2022/ Recomendac__o__es_de_rastreio_de_Tuberculose_em_cidada__os_provenientes_de_paises_de_alta_incide__ncia_de_TB.pdf

    BACKGROUND

MeSH Terms

Conditions

TuberculosisLatent Tuberculosis

Condition Hierarchy (Ancestors)

Mycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsLatent Infection

Study Officials

  • Ines Fronteira, PhD

    NOVA National School of Public Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ines Fronteira, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 12, 2026

First Posted

July 7, 2026

Study Start (Estimated)

December 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

July 7, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR